Neurological Research Services with Cell Signatures and Machine Learning
We provide unprecedented research services in the Neurology realm for scientists and companies alike. By seamlessly integrating machine learning power with deep clinical neurology expertise, we leverage our vast and comprehensive database to pioneer groundbreaking solutions for diagnosing brain disorders.
Transform Medicine and Science By D(R)EFINING DIAGNOSIS
We at Cell Signature Diagnostics GmbH are on a mission to revolutionize neurological and psychiatric diagnosis by using machine learning to analyze large and diverse data and provide accurate diagnosis, with innovative approaches and cutting-edge technology. We provide such research as a service.
The Problems We Solve
Neurological and psychiatric diseases are common and complex. They affect millions of people and their quality of life. Understanding disease an drug mechanisms in this complex field is often hard and costly. We facilitate the process of understanding.
Brain Disorders Are Hard To Diagnose
Brain disorders are hard to diagnose and require better solutions.
Drawbacks of Imaging
Imaging techniques for brain disorders are unspecific and need to be complemented.
Biomarker Scarcity
Biomarkers for brain disorders are scarce which limits diagnostic and treatment options.
Brain Disorders Affect Millions Worldwide
Brain disorders are a major public health issue and affect millions of people and their quality of life worldwide.
Comorbidity Complicates Diagnosis
Comorbidity is common in brain disorders and complicates diagnosis.
Insufficient Data
Data is scarce for brain disorders which limits the research and innovation potential.
The Solution
Transforming the Understanding
of Neurological Diseases With Machine Learning and Cell Signatures
How Our Technology and Approach Overcome the Challenges of Neurology
At the forefront of neuroscience, we harness the power of machine learning and cell signatures to process and interpret our available vast and diverse database from the brain and the nervous system. Our innovative approach delivers precise diagnoses for neurological disorders, revolutionizing the field of neurology and pschiatry.
Our cutting-edge approach ensures precise and personalized diagnoses, tailored to each individual's unique neurological profile.
By harnessing the power of existig and novel data and advanced analytics, we can identify patterns and markers that may have been overlooked by traditional methods, enabling us to provide targeted and effective diagnoses thus facilitating treatment.
Join us on this transformative journey as we push the boundaries of neuroscience, unlocking the secrets of the brain and paving the way for a future where neurological disorders are no longer a mystery but a challenge we can overcome together.
Machine Learning Has Already Revolutionized Various Domains, and We are Bringing Its Power to Clinical Neurology.
By using novel algorithms and accessing the world’s largest CSF data repository, we can unlock new insights and opportunities.
N > 15.000
Curated Data
Reliable and Accurate Solutions for Neurology
How Cell Signatures and Machine Learning Can Enhance Your Diagnosis and Treatment of Brain Diseases
Cell signatures, the unique molecular fingerprints that define different cell types, hold the key to accelerating research and driving therapeutic breakthroughs. By decoding these intricate cellular identities, you can navigate the intricate landscape of human biology and diagnosis with unprecedented precision
Unlock the Power of Precise Neuroinflammatory Disease Diagnosis With Unique Cell Signatures
Use cell signatures as a diagnostic test for neuroinflammatory diseases including multiple sclerosis (MS). Cell signatures can help to diagnose these diseases accurately and reliably.
Differentiate between different neuroinflammatory disease entities and assess prognosis with the power of Cell Signatures
These diseases affect the nervous system and involve inflammation of the brain, spinal cord, or peripheral nerves and can have different causes, symptoms, and outcomes, and can be challenging to diagnose and treat.
Accelerate Your Neurological Drug Discovery
Leveraging our unique database and algorithms that contain cell signatures and clinical data from thousands of patients with differentneuroinflammatory and MS diseases, you can de-risk your endeavors, accelerate your timelines, and unlock new frontiers in neurological drug discovery and development.
Harness machine learning to decipher cell signatures and biomarkers with greater depth
By using machine learning techniques you can extract meaningful insights from the complex data of cell signatures and other markers.
How We Can Help You
Our Services and Opportunities
We offer a range of services to diagnose and understand neurological diseases, such as:
Cerebrospinal fluid (CSF) and Blood Services
Associated Clinical Database
scRNA-/AIRR-seq Services
Bespoke Test Development
Commercialization and partnering opportunities
Our Team And Partners
Who We Are and How We Collaborate with Leading Neurology Centers and Institutions
We are a spin-off from University Hospital Münster, Germany in 2021. We were founded by high profile academic neurology clinician scientists.
We have a large network of clinical partners and collaborators across the world. We have a strong track record in establishing novel experimental and diagnostic procedures.
Meet the Founders
The people behind Cell Signature Diagnostics
Dr. Vera Rödel MHMM
CEO
Dr. Vera Rödel is a German lawyer with a Master's degree in Health and Medical Management. With over 12 years of experience in the pharmaceutical industry, she has led the Global Legal Neurology & Immunology and Cardio Metabolic & Endocrinology Team at Merck Legal Healthcare. Before joining Merck in 2014, Dr. Rödel worked at Boehringer Ingelheim and Linklaters LLP. In 2023, Dr. Rödel co-founded Prof. Valmed®, a pioneering platform for medical information retrieval, and assumed the role of CEO.
In addition, in 2024 Dr. Rödel founded transforming legal® a company bringing digital transformation and legal technology together while shaping the digital future of the legal profession.
Prof. Dr. Heinz Wiendl
Co-Founder, CSO
Prof. Dr Heinz Wiendl is Director of the Department of Neurology at Münster University Hospital and, among other things, spokesperson for the Collaborative Research Centre SFB TR128 Multiple Sclerosis - a national research network for the study of inflammatory diseases of the nervous system.
Thanks to this internationally visible scientific focus he will be instrumental in raising the company's profile among potential customers through his diverse professional networks. There are also long-standing scientific co-operation projects with diverse partners in the field of neurology.
Prof. Dr. Gerd Meyer zu Hörste
Co-Founder
Prof. Dr G. Meyer zu Hörste is managing senior physician at the Department of Neurology at Münster University Hospital and medical director of the clinic's cerebrospinal fluid laboratory, where flow cytometric analyses of cerebrospinal fluid cells have been carried out for many years.
One of his scientific focuses is the application of new analytical methods for a deep understanding of such high-throughput analyses in a patient-related context. Prof Dr G. Meyer zu Hörste is currently the Managing Director of CSD GmbH.
We are a team of experts with a common vision:
Revolutionize the field of neurological and psychiatric diagnostics and improve the lives of millions of people worldwide.
We are passionate about solving the challenges of brain disorders and creating innovative solutions that can make a difference. We have the experience, the knowledge, and the drive to achieve our mission.